- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Over The Counter (OTC) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Over The Counter (OTC) Drugs market size is estimated to be worth US$ 159420 million in 2021 and is forecast to a readjusted size of USD 216090 million by 2028 with a CAGR of 4.4% during review period. Hospital Pharmacies accounting for % of the Over The Counter (OTC) Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Analgesics segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Over The Counter (OTC) Drugs include Bayer AG, Merck KGaA, Novartis, Johnson & Johnson, and GlaxoSmithKline, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Over The Counter (OTC) Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Analgesics
Dermatology Products
Gastrointestinal Products
Vitamins, Mineral, and Supplements (VMS)
Weight Loss/Dietary Products
Ophthalmic Products
Sleeping Aids
Others
Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Others
Market segment by players, this report covers
Bayer AG
Merck KGaA
Novartis
Johnson & Johnson
GlaxoSmithKline
Alkem Laboratories
Teva Pharmaceutical Industries
Pfizer
Sun Pharma
Allergan
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Over The Counter (OTC) Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Over The Counter (OTC) Drugs, with revenue, gross margin and global market share of Over The Counter (OTC) Drugs from 2019 to 2022.
Chapter 3, the Over The Counter (OTC) Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Over The Counter (OTC) Drugs market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Over The Counter (OTC) Drugs research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Over The Counter (OTC) Drugs
1.2 Classification of Over The Counter (OTC) Drugs by Type
1.2.1 Overview: Global Over The Counter (OTC) Drugs Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Over The Counter (OTC) Drugs Revenue Market Share by Type in 2021
1.2.3 Analgesics
1.2.4 Dermatology Products
1.2.5 Gastrointestinal Products
1.2.6 Vitamins, Mineral, and Supplements (VMS)
1.2.7 Weight Loss/Dietary Products
1.2.8 Ophthalmic Products
1.2.9 Sleeping Aids
1.2.10 Others
1.3 Global Over The Counter (OTC) Drugs Market by Application
1.3.1 Overview: Global Over The Counter (OTC) Drugs Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Global Over The Counter (OTC) Drugs Market Size & Forecast
1.5 Global Over The Counter (OTC) Drugs Market Size and Forecast by Region
1.5.1 Global Over The Counter (OTC) Drugs Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Over The Counter (OTC) Drugs Market Size by Region, (2017-2022)
1.5.3 North America Over The Counter (OTC) Drugs Market Size and Prospect (2017-2028)
1.5.4 Europe Over The Counter (OTC) Drugs Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Over The Counter (OTC) Drugs Market Size and Prospect (2017-2028)
1.5.6 South America Over The Counter (OTC) Drugs Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Over The Counter (OTC) Drugs Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Over The Counter (OTC) Drugs Market Drivers
1.6.2 Over The Counter (OTC) Drugs Market Restraints
1.6.3 Over The Counter (OTC) Drugs Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Bayer AG
2.1.1 Bayer AG Details
2.1.2 Bayer AG Major Business
2.1.3 Bayer AG Over The Counter (OTC) Drugs Product and Solutions
2.1.4 Bayer AG Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Bayer AG Recent Developments and Future Plans
2.2 Merck KGaA
2.2.1 Merck KGaA Details
2.2.2 Merck KGaA Major Business
2.2.3 Merck KGaA Over The Counter (OTC) Drugs Product and Solutions
2.2.4 Merck KGaA Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Merck KGaA Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Over The Counter (OTC) Drugs Product and Solutions
2.3.4 Novartis Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Over The Counter (OTC) Drugs Product and Solutions
2.4.4 Johnson & Johnson Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Over The Counter (OTC) Drugs Product and Solutions
2.5.4 GlaxoSmithKline Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 GlaxoSmithKline Recent Developments and Future Plans
2.6 Alkem Laboratories
2.6.1 Alkem Laboratories Details
2.6.2 Alkem Laboratories Major Business
2.6.3 Alkem Laboratories Over The Counter (OTC) Drugs Product and Solutions
2.6.4 Alkem Laboratories Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Alkem Laboratories Recent Developments and Future Plans
2.7 Teva Pharmaceutical Industries
2.7.1 Teva Pharmaceutical Industries Details
2.7.2 Teva Pharmaceutical Industries Major Business
2.7.3 Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Product and Solutions
2.7.4 Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Over The Counter (OTC) Drugs Product and Solutions
2.8.4 Pfizer Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Sun Pharma
2.9.1 Sun Pharma Details
2.9.2 Sun Pharma Major Business
2.9.3 Sun Pharma Over The Counter (OTC) Drugs Product and Solutions
2.9.4 Sun Pharma Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Sun Pharma Recent Developments and Future Plans
2.10 Allergan
2.10.1 Allergan Details
2.10.2 Allergan Major Business
2.10.3 Allergan Over The Counter (OTC) Drugs Product and Solutions
2.10.4 Allergan Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Allergan Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Over The Counter (OTC) Drugs Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Over The Counter (OTC) Drugs Players Market Share in 2021
3.2.2 Top 10 Over The Counter (OTC) Drugs Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Over The Counter (OTC) Drugs Players Head Office, Products and Services Provided
3.4 Over The Counter (OTC) Drugs Mergers & Acquisitions
3.5 Over The Counter (OTC) Drugs New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Over The Counter (OTC) Drugs Revenue and Market Share by Type (2017-2022)
4.2 Global Over The Counter (OTC) Drugs Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Over The Counter (OTC) Drugs Revenue Market Share by Application (2017-2022)
5.2 Global Over The Counter (OTC) Drugs Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Over The Counter (OTC) Drugs Revenue by Type (2017-2028)
6.2 North America Over The Counter (OTC) Drugs Revenue by Application (2017-2028)
6.3 North America Over The Counter (OTC) Drugs Market Size by Country
6.3.1 North America Over The Counter (OTC) Drugs Revenue by Country (2017-2028)
6.3.2 United States Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
6.3.3 Canada Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
6.3.4 Mexico Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Over The Counter (OTC) Drugs Revenue by Type (2017-2028)
7.2 Europe Over The Counter (OTC) Drugs Revenue by Application (2017-2028)
7.3 Europe Over The Counter (OTC) Drugs Market Size by Country
7.3.1 Europe Over The Counter (OTC) Drugs Revenue by Country (2017-2028)
7.3.2 Germany Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
7.3.3 France Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
7.3.5 Russia Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
7.3.6 Italy Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Over The Counter (OTC) Drugs Revenue by Type (2017-2028)
8.2 Asia-Pacific Over The Counter (OTC) Drugs Revenue by Application (2017-2028)
8.3 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region
8.3.1 Asia-Pacific Over The Counter (OTC) Drugs Revenue by Region (2017-2028)
8.3.2 China Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
8.3.3 Japan Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
8.3.4 South Korea Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
8.3.5 India Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
8.3.7 Australia Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Over The Counter (OTC) Drugs Revenue by Type (2017-2028)
9.2 South America Over The Counter (OTC) Drugs Revenue by Application (2017-2028)
9.3 South America Over The Counter (OTC) Drugs Market Size by Country
9.3.1 South America Over The Counter (OTC) Drugs Revenue by Country (2017-2028)
9.3.2 Brazil Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
9.3.3 Argentina Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Over The Counter (OTC) Drugs Revenue by Type (2017-2028)
10.2 Middle East & Africa Over The Counter (OTC) Drugs Revenue by Application (2017-2028)
10.3 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country
10.3.1 Middle East & Africa Over The Counter (OTC) Drugs Revenue by Country (2017-2028)
10.3.2 Turkey Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
10.3.4 UAE Over The Counter (OTC) Drugs Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Over The Counter (OTC) Drugs Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Over The Counter (OTC) Drugs Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Over The Counter (OTC) Drugs Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Over The Counter (OTC) Drugs Revenue (USD Million) by Region (2017-2022)
Table 5. Global Over The Counter (OTC) Drugs Revenue Market Share by Region (2023-2028)
Table 6. Bayer AG Corporate Information, Head Office, and Major Competitors
Table 7. Bayer AG Major Business
Table 8. Bayer AG Over The Counter (OTC) Drugs Product and Solutions
Table 9. Bayer AG Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Merck KGaA Corporate Information, Head Office, and Major Competitors
Table 11. Merck KGaA Major Business
Table 12. Merck KGaA Over The Counter (OTC) Drugs Product and Solutions
Table 13. Merck KGaA Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Over The Counter (OTC) Drugs Product and Solutions
Table 17. Novartis Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 19. Johnson & Johnson Major Business
Table 20. Johnson & Johnson Over The Counter (OTC) Drugs Product and Solutions
Table 21. Johnson & Johnson Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 23. GlaxoSmithKline Major Business
Table 24. GlaxoSmithKline Over The Counter (OTC) Drugs Product and Solutions
Table 25. GlaxoSmithKline Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Alkem Laboratories Corporate Information, Head Office, and Major Competitors
Table 27. Alkem Laboratories Major Business
Table 28. Alkem Laboratories Over The Counter (OTC) Drugs Product and Solutions
Table 29. Alkem Laboratories Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Teva Pharmaceutical Industries Corporate Information, Head Office, and Major Competitors
Table 31. Teva Pharmaceutical Industries Major Business
Table 32. Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Product and Solutions
Table 33. Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Pfizer Corporate Information, Head Office, and Major Competitors
Table 35. Pfizer Major Business
Table 36. Pfizer Over The Counter (OTC) Drugs Product and Solutions
Table 37. Pfizer Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Sun Pharma Corporate Information, Head Office, and Major Competitors
Table 39. Sun Pharma Major Business
Table 40. Sun Pharma Over The Counter (OTC) Drugs Product and Solutions
Table 41. Sun Pharma Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Allergan Corporate Information, Head Office, and Major Competitors
Table 43. Allergan Major Business
Table 44. Allergan Over The Counter (OTC) Drugs Product and Solutions
Table 45. Allergan Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Over The Counter (OTC) Drugs Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Over The Counter (OTC) Drugs Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Over The Counter (OTC) Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Over The Counter (OTC) Drugs Players Head Office, Products and Services Provided
Table 50. Over The Counter (OTC) Drugs Mergers & Acquisitions in the Past Five Years
Table 51. Over The Counter (OTC) Drugs New Entrants and Expansion Plans
Table 52. Global Over The Counter (OTC) Drugs Revenue (USD Million) by Type (2017-2022)
Table 53. Global Over The Counter (OTC) Drugs Revenue Share by Type (2017-2022)
Table 54. Global Over The Counter (OTC) Drugs Revenue Forecast by Type (2023-2028)
Table 55. Global Over The Counter (OTC) Drugs Revenue by Application (2017-2022)
Table 56. Global Over The Counter (OTC) Drugs Revenue Forecast by Application (2023-2028)
Table 57. North America Over The Counter (OTC) Drugs Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Over The Counter (OTC) Drugs Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Over The Counter (OTC) Drugs Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Over The Counter (OTC) Drugs Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Over The Counter (OTC) Drugs Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Over The Counter (OTC) Drugs Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Over The Counter (OTC) Drugs Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Over The Counter (OTC) Drugs Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Over The Counter (OTC) Drugs Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Over The Counter (OTC) Drugs Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Over The Counter (OTC) Drugs Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Over The Counter (OTC) Drugs Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Over The Counter (OTC) Drugs Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Over The Counter (OTC) Drugs Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Over The Counter (OTC) Drugs Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Over The Counter (OTC) Drugs Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Over The Counter (OTC) Drugs Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Over The Counter (OTC) Drugs Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Over The Counter (OTC) Drugs Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Over The Counter (OTC) Drugs Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Over The Counter (OTC) Drugs Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Over The Counter (OTC) Drugs Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Over The Counter (OTC) Drugs Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Over The Counter (OTC) Drugs Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Over The Counter (OTC) Drugs Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Over The Counter (OTC) Drugs Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Over The Counter (OTC) Drugs Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Over The Counter (OTC) Drugs Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Over The Counter (OTC) Drugs Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Over The Counter (OTC) Drugs Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Over The Counter (OTC) Drugs Picture
Figure 2. Global Over The Counter (OTC) Drugs Revenue Market Share by Type in 2021
Figure 3. Analgesics
Figure 4. Dermatology Products
Figure 5. Gastrointestinal Products
Figure 6. Vitamins, Mineral, and Supplements (VMS)
Figure 7. Weight Loss/Dietary Products
Figure 8. Ophthalmic Products
Figure 9. Sleeping Aids
Figure 10. Others
Figure 11. Over The Counter (OTC) Drugs Revenue Market Share by Application in 2021
Figure 12. Hospital Pharmacies Picture
Figure 13. Retail Pharmacies Picture
Figure 14. Online Pharmacy Picture
Figure 15. Others Picture
Figure 16. Global Over The Counter (OTC) Drugs Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 17. Global Over The Counter (OTC) Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 18. Global Over The Counter (OTC) Drugs Revenue Market Share by Region (2017-2028)
Figure 19. Global Over The Counter (OTC) Drugs Revenue Market Share by Region in 2021
Figure 20. North America Over The Counter (OTC) Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Europe Over The Counter (OTC) Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Asia-Pacific Over The Counter (OTC) Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. South America Over The Counter (OTC) Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 24. Middle East and Africa Over The Counter (OTC) Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 25. Over The Counter (OTC) Drugs Market Drivers
Figure 26. Over The Counter (OTC) Drugs Market Restraints
Figure 27. Over The Counter (OTC) Drugs Market Trends
Figure 28. Bayer AG Recent Developments and Future Plans
Figure 29. Merck KGaA Recent Developments and Future Plans
Figure 30. Novartis Recent Developments and Future Plans
Figure 31. Johnson & Johnson Recent Developments and Future Plans
Figure 32. GlaxoSmithKline Recent Developments and Future Plans
Figure 33. Alkem Laboratories Recent Developments and Future Plans
Figure 34. Teva Pharmaceutical Industries Recent Developments and Future Plans
Figure 35. Pfizer Recent Developments and Future Plans
Figure 36. Sun Pharma Recent Developments and Future Plans
Figure 37. Allergan Recent Developments and Future Plans
Figure 38. Global Over The Counter (OTC) Drugs Revenue Share by Players in 2021
Figure 39. Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 40. Global Top 3 Players Over The Counter (OTC) Drugs Revenue Market Share in 2021
Figure 41. Global Top 10 Players Over The Counter (OTC) Drugs Revenue Market Share in 2021
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 43. Global Over The Counter (OTC) Drugs Revenue Share by Type in 2021
Figure 44. Global Over The Counter (OTC) Drugs Market Share Forecast by Type (2023-2028)
Figure 45. Global Over The Counter (OTC) Drugs Revenue Share by Application in 2021
Figure 46. Global Over The Counter (OTC) Drugs Market Share Forecast by Application (2023-2028)
Figure 47. North America Over The Counter (OTC) Drugs Sales Market Share by Type (2017-2028)
Figure 48. North America Over The Counter (OTC) Drugs Sales Market Share by Application (2017-2028)
Figure 49. North America Over The Counter (OTC) Drugs Revenue Market Share by Country (2017-2028)
Figure 50. United States Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Canada Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Mexico Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Europe Over The Counter (OTC) Drugs Sales Market Share by Type (2017-2028)
Figure 54. Europe Over The Counter (OTC) Drugs Sales Market Share by Application (2017-2028)
Figure 55. Europe Over The Counter (OTC) Drugs Revenue Market Share by Country (2017-2028)
Figure 56. Germany Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. France Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. United Kingdom Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Russia Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Italy Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Asia-Pacific Over The Counter (OTC) Drugs Sales Market Share by Type (2017-2028)
Figure 62. Asia-Pacific Over The Counter (OTC) Drugs Sales Market Share by Application (2017-2028)
Figure 63. Asia-Pacific Over The Counter (OTC) Drugs Revenue Market Share by Region (2017-2028)
Figure 64. China Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Japan Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South Korea Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. India Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Southeast Asia Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Australia Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South America Over The Counter (OTC) Drugs Sales Market Share by Type (2017-2028)
Figure 71. South America Over The Counter (OTC) Drugs Sales Market Share by Application (2017-2028)
Figure 72. South America Over The Counter (OTC) Drugs Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East and Africa Over The Counter (OTC) Drugs Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Over The Counter (OTC) Drugs Sales Market Share by Application (2017-2028)
Figure 77. Middle East and Africa Over The Counter (OTC) Drugs Revenue Market Share by Country (2017-2028)
Figure 78. Turkey Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. UAE Over The Counter (OTC) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
